A detailed history of Affinity Asset Advisors, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 860,399 shares of NRIX stock, worth $17.2 Million. This represents 3.34% of its overall portfolio holdings.

Number of Shares
860,399
Previous 912,000 5.66%
Holding current value
$17.2 Million
Previous $19 Million 1.48%
% of portfolio
3.34%
Previous 2.59%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$18.93 - $25.69 $976,806 - $1.33 Million
-51,601 Reduced 5.66%
860,399 $19.3 Million
Q2 2024

Aug 14, 2024

BUY
$12.02 - $21.3 $1.22 Million - $2.17 Million
101,747 Added 12.56%
912,000 $19 Million
Q1 2024

May 14, 2024

BUY
$7.77 - $15.66 $933,495 - $1.88 Million
120,141 Added 17.41%
810,253 $11.9 Million
Q4 2023

Feb 13, 2024

BUY
$4.25 - $10.71 $1.87 Million - $4.71 Million
440,112 Added 176.04%
690,112 $7.12 Million
Q3 2023

Nov 14, 2023

BUY
$7.86 - $10.08 $1.18 Million - $1.51 Million
150,000 Added 150.0%
250,000 $1.97 Million
Q2 2023

Aug 14, 2023

SELL
$8.7 - $13.28 $434,999 - $664,000
-50,000 Reduced 33.33%
100,000 $999,000
Q1 2023

May 15, 2023

BUY
$8.56 - $13.26 $599,200 - $928,200
70,000 Added 87.5%
150,000 $1.33 Million
Q4 2022

Feb 13, 2023

BUY
$9.86 - $14.59 $788,800 - $1.17 Million
80,000 New
80,000 $878,000

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $942M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.